Macroplane › Companies › 心誠鎂

心誠鎂 (6934)

Sector: Healthcare · Industry: 化學生技醫療 · Exchange: TWSE

About 心誠鎂

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia. The company's products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides intellectual property, advanced technology, customization platforms, manufacturing and commercialization, and APSD analytical services. The company was founded in 2014 and is headquartered in Taipei, Taiwan.

Headquarters: Taipei, TW · Website: https://www.hcmed-inno.com

Frequently asked questions about 心誠鎂 (6934)

What is 心誠鎂 (6934)?

心誠鎂 (6934) is a publicly traded company in the Healthcare sector (化學生技醫療), listed on TWSE. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Search companies · Macro trends · Industries · Product categories · Baskets